Compare OBIO & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OBIO | SEVN |
|---|---|---|
| Founded | 2017 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.2M | 191.2M |
| IPO Year | 2020 | 2008 |
| Metric | OBIO | SEVN |
|---|---|---|
| Price | $4.21 | $8.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $14.25 | $11.50 |
| AVG Volume (30 Days) | ★ 190.6K | 91.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | ★ 33.13 | N/A |
| EPS | N/A | ★ 1.00 |
| Revenue | ★ $33,482,000.00 | $29,383,000.00 |
| Revenue This Year | N/A | $27.75 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $8.46 |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.20 | $8.30 |
| 52 Week High | $5.42 | $13.02 |
| Indicator | OBIO | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.22 | 33.11 |
| Support Level | $4.00 | N/A |
| Resistance Level | $5.00 | $8.95 |
| Average True Range (ATR) | 0.27 | 0.17 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 29.74 | 3.03 |
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.